Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial
- Xia Zhang
- Ruiling Feng
- Yifan Wang
- Wenqiang Fan
- Xiao Gao
- Miaomiao Ma
- Guanmin Gao
- Dongbin Jiang
- Ting Li
- Huifang Guo
- Lingyan Lei
- Ke Xu
- Yucui Li
- Kuanting Wang
- Yan Ding
- Wei Wei
- Na Zhang
- Wenping Pan
- Qingwen Wang
- Juan He
- Yueming Cai
- Tongjun Mao
- Ruijun Zhang
- Rong Mu
- Yongfu Wang
- Hui Wang
- Yuan Jia
- Xiaolin Sun
- Zhanguo Li
- Jing He
2026-04-21